Synthetic Biology Based Therapeutics Summit
RhiaPharmaceutical’s Graham Whyteside, PhD, Director, Platform R&D, RhiaPharmaceutical Europe, spoke at the Synthetic Biology-Based Therapeutic Summit on Advancing Synthetic Promoter Design.
RhiaPharmaceutical’s Graham Whyteside, PhD, Director, Platform R&D, RhiaPharmaceutical Europe, spoke at the Synthetic Biology-Based Therapeutic Summit on Advancing Synthetic Promoter Design.